 |
인쇄하기
취소
|
MOIE to investigate Gemcitabine patent infringement.
The Trade Commission of the Ministry of Industry and Energy took the 225th meeting on Nov. 12 and decided to investigate an unfair trade act by infringing the patent rights of gemcitabine, an anti-cancer drug owned by E. Lilly.
E. Lilly claimed that local "K" and "S" drug company imported a bulk material of gemcitabine from India for production and sale of its finished products, which defini...
E. Lilly claimed that local "K" and "S" drug company imported a bulk material of gemcitabine from India for production and sale of its finished products, which defini...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.